<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RAG Literature Analysis - SMCHD1</title>
    <style>
        :root {
            --primary-color: #2c3e50;
            --secondary-color: #3498db;
            --success-color: #27ae60;
            --warning-color: #f39c12;
            --danger-color: #e74c3c;
            --light-bg: #f8f9fa;
            --border-color: #dee2e6;
        }
        
        * { margin: 0; padding: 0; box-sizing: border-box; }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            line-height: 1.6;
            color: #333;
            background-color: #f5f7fa;
            padding: 20px;
        }
        
        .container { max-width: 1200px; margin: 0 auto; background: white; padding: 30px; border-radius: 10px; box-shadow: 0 2px 10px rgba(0,0,0,0.1); }
        
        header {
            text-align: center;
            margin-bottom: 30px;
            padding-bottom: 20px;
            border-bottom: 3px solid var(--secondary-color);
        }
        
        h1 { color: var(--primary-color); font-size: 2em; margin-bottom: 10px; }
        .subtitle { color: #666; font-size: 1.1em; }
        
        .prediction-card {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 25px;
            border-radius: 10px;
            margin-bottom: 30px;
            text-align: center;
        }
        
        .prediction-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin-top: 20px;
        }
        
        .prediction-item {
            background: rgba(255,255,255,0.2);
            padding: 15px;
            border-radius: 8px;
        }
        
        .prediction-value {
            font-size: 1.8em;
            font-weight: bold;
            margin-bottom: 5px;
        }
        
        .prediction-label { font-size: 0.9em; opacity: 0.9; }
        
        .severity-badge, .risk-badge {
            display: inline-block;
            padding: 8px 16px;
            border-radius: 20px;
            font-weight: bold;
            text-transform: uppercase;
            font-size: 0.9em;
        }
        
        .section {
            margin: 30px 0;
            padding: 20px;
            background: var(--light-bg);
            border-radius: 8px;
        }
        
        .section-title {
            color: var(--primary-color);
            border-bottom: 2px solid var(--secondary-color);
            padding-bottom: 10px;
            margin-bottom: 20px;
            font-size: 1.4em;
        }
        
        .publication {
            background: white;
            padding: 20px;
            margin-bottom: 15px;
            border-radius: 8px;
            border-left: 4px solid var(--secondary-color);
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }
        
        .pub-title {
            font-weight: bold;
            color: var(--primary-color);
            margin-bottom: 8px;
            font-size: 1.1em;
        }
        
        .pub-meta {
            color: #666;
            font-size: 0.9em;
            margin-bottom: 10px;
        }
        
        .pub-abstract {
            color: #333;
            line-height: 1.6;
            margin-top: 10px;
            padding-top: 10px;
            border-top: 1px solid #eee;
        }
        
        .pub-links {
            margin-top: 10px;
        }
        
        .pub-links a {
            display: inline-block;
            margin-right: 15px;
            color: var(--secondary-color);
            text-decoration: none;
            font-weight: 500;
        }
        
        .pub-links a:hover { text-decoration: underline; }
        
        .evidence-quality {
            display: inline-block;
            padding: 3px 8px;
            border-radius: 4px;
            font-size: 0.8em;
            font-weight: bold;
            text-transform: uppercase;
        }
        
        .evidence-high { background: #d4edda; color: #155724; }
        .evidence-medium { background: #fff3cd; color: #856404; }
        .evidence-low { background: #f8d7da; color: #721c24; }
        
        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(150px, 1fr));
            gap: 15px;
            margin: 20px 0;
        }
        
        .stat-box {
            background: white;
            padding: 15px;
            border-radius: 8px;
            text-align: center;
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }
        
        .stat-value {
            font-size: 1.5em;
            font-weight: bold;
            color: var(--secondary-color);
        }
        
        .stat-label {
            font-size: 0.85em;
            color: #666;
            margin-top: 5px;
        }
        
        .phenotypes-list {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-top: 15px;
        }
        
        .phenotype-tag {
            background: var(--secondary-color);
            color: white;
            padding: 5px 12px;
            border-radius: 15px;
            font-size: 0.9em;
        }
        
        .confidence-bar {
            height: 20px;
            background: #e9ecef;
            border-radius: 10px;
            overflow: hidden;
            margin-top: 10px;
        }
        
        .confidence-fill {
            height: 100%;
            background: linear-gradient(90deg, #dc3545 0%, #ffc107 50%, #28a745 100%);
            border-radius: 10px;
            transition: width 0.3s ease;
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>ðŸ“š RAG Literature Analysis Report</h1>
            <div class="subtitle">
                Gene: <strong>SMCHD1</strong> | 
                Organism TaxID: <strong>9606</strong>
            </div>
        </header>
        
        <div class="prediction-card">
            <h2>ðŸŽ¯ Phenotype Prediction Summary</h2>
            <div class="prediction-grid">
                <div class="prediction-item">
                    <div class="prediction-value">UNKNOWN</div>
                    <div class="prediction-label">Severity</div>
                </div>
                <div class="prediction-item">
                    <div class="prediction-value">UNKNOWN</div>
                    <div class="prediction-label">Risk Level</div>
                </div>
                <div class="prediction-item">
                    <div class="prediction-value">40%</div>
                    <div class="prediction-label">Confidence</div>
                </div>
            </div>
            <div class="confidence-bar">
                <div class="confidence-fill" style="width: 40.0%"></div>
            </div>
        </div>
        
        <div class="section">
            <h2 class="section-title">ðŸ“Š Literature Mining Statistics</h2>
            <div class="stats-grid">
                <div class="stat-box">
                    <div class="stat-value">53</div>
                    <div class="stat-label">Publications Retrieved</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">46</div>
                    <div class="stat-label">Open Access (PMC)</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">0</div>
                    <div class="stat-label">High-Quality Evidence</div>
                </div>
            </div>
        </div>

        <div class="section">
            <h2 class="section-title">ðŸ“– Key Supporting Evidence</h2>

            <div class="publication" style="border-left-color: #28a745;">
                <div class="pub-abstract"></div>
                <div class="pub-meta">Source: Unknown</div>
            </div>

        </div>

        <div class="section">
            <h2 class="section-title">ðŸ“š Retrieved Publications (53)</h2>

            <div class="publication">
                <div class="pub-title">Facioscapulohumeral muscular dystrophy.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Neurologic clinics | 
                    2014 | 
                    PMID: 25037087
                </div>
                <div class="pub-abstract">Facioscapulohumeral muscular dystrophy (FSHD) is a common type of adult muscular dystrophy and is divided into types 1 and 2 based on genetic mutation. Clinically, both FSHD types often show asymmetric and progressive muscle weakness affecting initially the face, shoulder, and arms followed by the distal then proximal lower extremities. Approximately 95% of patients, termed FSHD1, have a deletion of a key number of repetitive elements on chromosome 4q35. The remaining 5%, termed FSHD2, have no deletion on chromosome 4q35. Nevertheless, both types share a common downstream mechanism, making it possible for future disease-directed therapies to be effective for both FSHD types.</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25037087/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239655/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Facioscapulohumeral Muscular Dystrophies.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Continuum (Minneapolis, Minn.) | 
                    2019 | 
                    PMID: 31794465
                </div>
                <div class="pub-abstract">Facioscapulohumeral muscular dystrophy (FSHD) is a common muscular dystrophy affecting both pediatric and adult patients. This article reviews the phenotype and pathophysiology of the disease as well as the recent efforts in clinical outcome measures and clinical trials. As the name implies, FSHD involves weakness of facial muscles, muscles that fix the scapula, and muscles overlying the humerus (biceps and triceps). The distinctive phenotype of FSHD occurs secondary to two different genetic mechanisms. FSHD type 1 (FSHD1) is due to a deletion on chromosome 4q, leading to hypomethylation and derepression of DUX4. FSHD type 2 (FSHD2) is due to mutations in SMCHD1 with resulting hypomethylation of the same subtelomeric region of chromosome 4q and derepression of DUX4. Understanding the centr...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31794465/" target="_blank">View on PubMed</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Genotype-phenotype correlations in FSHD.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    BMC medical genomics | 
                    2019 | 
                    PMID: 30871534
                </div>
                <div class="pub-abstract">Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle. There are two types of the disease: FSHD1 (MIM:158900) and FSHD2 (MIM: 158901), which have different genetic causes but are phenotypically indistinguishable. In FSHD1, partial deletion of the D4Z4 repeats on the 4th chromosome affects the expression of DUX4, whereas FSHD2 is caused by the mutations in the protein regulating the methylation status of chromatin - SMCHD1. High variability of clinical picture, both intra - and inter-family indicates a large number of factors influencing clinical picture. There are key genetic, epigenetic and gender factors that influence the expressivity and pene...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30871534/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416831/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Facioscapulohumeral Muscular Dystrophy.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Continuum (Minneapolis, Minn.) | 
                    2016 | 
                    PMID: 27922500
                </div>
                <div class="pub-abstract">This article describes the clinical characteristics, diagnosis, molecular pathogenesis, and treatment of facioscapulohumeral muscular dystrophy (FSHD). FSHD comprises two genetically distinct types that converge on a common downstream pathway of the expression of the toxic protein DUX4. Approximately 95% of patients have FSHD type 1 (FSHD1), in which loss of DNA repetitive elements (D4Z4 repeats) in the subtelomeric region of chromosome 4q causes decreased methylation and epigenetic derepression of DUX4, a gene contained within each D4Z4 repeat. FSHD type 2 (FSHD2) occurs through a deletion-independent mechanism but, similar to FSHD1, leads to decreased methylation and epigenetic derepression in the same region of chromosome 4q. Whereas FSHD1 is dominantly inherited, FSHD2 shows digenic in...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/27922500/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898965/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">HOX epimutations driven by maternal SMCHD1/LRIF1 haploinsufficiency trigger homeotic transformations in genetically wildtype offspring.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Nature communications | 
                    2022 | 
                    PMID: 35739109
                </div>
                <div class="pub-abstract">The body plan of animals is laid out by an evolutionary-conserved HOX code which is colinearly transcribed after zygotic genome activation (ZGA). Here we report that SMCHD1, a chromatin-modifying enzyme needed for X-inactivation in mammals, is maternally required for timely HOX expression. Using zebrafish and mouse Smchd1 knockout animals, we demonstrate that Smchd1 haplo-insufficiency brings about precocious and ectopic HOX transcription during oogenesis and embryogenesis. Unexpectedly, wild-type offspring born to heterozygous knockout zebrafish smchd1 mothers exhibited patent vertebrate patterning defects. The loss of maternal Smchd1 was accompanied by HOX epi-mutations driven by aberrant DNA methylation. We further show that this regulation is mediated by Lrif1, a direct interacting par...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35739109/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226161/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Genome-Wide CRISPR-Cas9 Screen Identifies SMCHD1 as a Restriction Factor for Herpesviruses.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    mBio | 
                    2023 | 
                    PMID: 37010434
                </div>
                <div class="pub-abstract">Intrinsic immunity is the frontline of host defense against invading pathogens. To combat viral infection, mammalian hosts deploy cell-intrinsic effectors to block viral replication prior to the onset of innate and adaptive immunity. In this study, SMCHD1 is identified as a pivotal cellular factor that restricts Kaposi&#x27;s sarcoma-associated herpesvirus (KSHV) lytic reactivation through a genome-wide CRISPR-Cas9 knockout screen. Genome-wide chromatin profiling revealed that SMCHD1 associates with the KSHV genome, most prominently the origin of lytic DNA replication (ORI-Lyt). SMCHD1 mutants defective in DNA binding could not bind ORI-Lyt and failed to restrict KSHV lytic replication. Moreover, SMCHD1 functioned as a pan-herpesvirus restriction factor that potently suppressed a wide range of ...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/37010434/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128004/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">SMCHD1 promotes ATM-dependent DNA damage signaling and repair of uncapped telomeres.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    The EMBO journal | 
                    2020 | 
                    PMID: 32080884
                </div>
                <div class="pub-abstract">Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMCHD1) has been implicated in X-chromosome inactivation, imprinting, and DNA damage repair, and mutations in SMCHD1 can cause facioscapulohumeral muscular dystrophy. More recently, SMCHD1 has also been identified as a component of telomeric chromatin. Here, we report that SMCHD1 is required for DNA damage signaling and non-homologous end joining (NHEJ) at unprotected telomeres. Co-depletion of SMCHD1 and the shelterin subunit TRF2 reduced telomeric 3&#x27;-overhang removal in time-course experiments, as well as the number of chromosome end fusions. SMCHD1-deficient cells displayed reduced ATM S1981 phosphorylation and diminished formation of Î³H2AX foci and of 53BP1-containing telomere dysfunction-induced foci (TI...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32080884/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110143/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    BMC genetics | 
                    2020 | 
                    PMID: 31941450
                </div>
                <div class="pub-abstract">DNA methylation is an epigenetic modification that mainly repress expression of genes essential during embryogenesis and development. There are key ATPase-dependent enzymes that read or write DNA methylation to remodel chromatin and regulate gene expression. Structural maintenance of chromosome hinge domain containing 1 (SMCHD1) is an architectural protein that regulates expression of numerous genes, some of which are imprinted, that are sensitive to DNA methylation. In addition, SMCHD1 germline mutations lead to developmental diseases; facioscapulohumoral muscular dystrophy (FSHD), bosma arhinia and micropthalmia (BAMS). Current evidence suggests that SMCHD1 functions through maintenance or de novo DNA methylation required for chromatin compaction. However, it is unclear if DNA methylatio...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31941450/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964063/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">SMCHD1&#x27;s ubiquitin-like domain is required for N-terminal dimerization and chromatin localization.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    The Biochemical journal | 
                    2021 | 
                    PMID: 34109974
                </div>
                <div class="pub-abstract">Structural maintenance of chromosomes flexible hinge domain-containing 1 (SMCHD1) is an epigenetic regulator that mediates gene expression silencing at targeted sites across the genome. Our current understanding of SMCHD1&#x27;s molecular mechanism, and how substitutions within SMCHD1 lead to the diseases, facioscapulohumeral muscular dystrophy (FSHD) and Bosma arhinia microphthalmia syndrome (BAMS), are only emerging. Recent structural studies of its two component domains - the N-terminal ATPase and C-terminal SMC hinge - suggest that dimerization of each domain plays a central role in SMCHD1 function. Here, using biophysical techniques, we demonstrate that the SMCHD1 ATPase undergoes dimerization in a process that is dependent on both the N-terminal UBL (Ubiquitin-like) domain and ATP binding...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/34109974/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286825/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">The non-canonical SMC protein SmcHD1 antagonises TAD formation and compartmentalisation on the inactive X chromosome.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Nature communications | 
                    2019 | 
                    PMID: 30604745
                </div>
                <div class="pub-abstract">The inactive X chromosome (Xi) in female mammals adopts an atypical higher-order chromatin structure, manifested as a global loss of local topologically associated domains (TADs), A/B compartments and formation of two mega-domains. Here we demonstrate that the non-canonical SMC family protein, SmcHD1, which is important for gene silencing on Xi, contributes to this unique chromosome architecture. Specifically, allelic mapping of the transcriptome and epigenome in SmcHD1 mutant cells reveals the appearance of sub-megabase domains defined by gene activation, CpG hypermethylation and depletion of Polycomb-mediated H3K27me3. These domains, which correlate with sites of SmcHD1 enrichment on Xi in wild-type cells, additionally adopt features of active X chromosome higher-order chromosome archite...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30604745/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318279/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Smchd1 regulates long-range chromatin interactions on the inactive X chromosome and at Hox clusters.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Nature structural &amp; molecular biology | 
                    2018 | 
                    PMID: 30127357
                </div>
                <div class="pub-abstract">The regulation of higher-order chromatin structure is complex and dynamic, and a full understanding of the suite of mechanisms governing this architecture is lacking. Here, we reveal the noncanonical SMC protein Smchd1 to be a novel regulator of long-range chromatin interactions in mice, and we add Smchd1 to the canon of epigenetic proteins required for Hox-gene regulation. The effect of losing Smchd1-dependent chromatin interactions has varying outcomes that depend on chromatin context. At autosomal targets transcriptionally sensitive to Smchd1 deletion, we found increased short-range interactions and ectopic enhancer activation. In contrast, the inactive X chromosome was transcriptionally refractive to Smchd1 ablation, despite chromosome-wide increases in short-range interactions. In the...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30127357/" target="_blank">View on PubMed</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Journal of medical genetics | 
                    2018 | 
                    PMID: 29563141
                </div>
                <div class="pub-abstract">18p deletion syndrome is a rare disorder caused by partial or full monosomy of the short arm of chromosome 18. Clinical symptoms caused by 18p hemizygosity include cognitive impairment, mild facial dysmorphism, strabismus and ptosis. Among other genes, structural maintenance of chromosomes flexible hinge domain containing 1 ( Since 12% of Caucasian individuals harbour moderately sized D4Z4 repeats on an FSHD permissive background, we tested if people with 18p deletions are at risk of developing FSHD. To test our hypothesis we studied different cellular systems originating from individuals with 18p deletions not presenting FSHD2 phenotype for transcriptional and epigenetic characteristics of FSHD at D4Z4. Furthermore, individuals with an idiopathic muscle phenotype and an 18p deletion were ...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29563141/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019561/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Genome-wide CRISPR screenings identified SMCHD1 as a host-restricting factor for AAV transduction.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    PLoS pathogens | 
                    2024 | 
                    PMID: 38976714
                </div>
                <div class="pub-abstract">AAV-mediated gene therapy typically requires a high dose of viral transduction, risking acute immune responses and patient safety, part of which is due to limited understanding of the host-viral interactions, especially post-transduction viral genome processing. Here, through a genome-wide CRISPR screen, we identified SMCHD1 (Structural Maintenance of Chromosomes Hinge Domain 1), an epigenetic modifier, as a critical broad-spectrum restricting host factor for post-entry AAV transgene expression. SMCHD1 knock-down by RNAi and CRISPRi or knock-out by CRISPR all resulted in significantly enhanced transgene expression across multiple viral serotypes, as well as for both single-strand and self-complementary AAV genome types. Mechanistically, upon viral transduction, SMCHD1 effectively repressed...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/38976714/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257396/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Human mutation | 
                    2015 | 
                    PMID: 25820463
                </div>
                <div class="pub-abstract">Facioscapulohumeral muscular dystrophy (FSHD) is most often associated with variegated expression in somatic cells of the normally repressed DUX4 gene within the D4Z4-repeat array. The most common form, FSHD1, is caused by a D4Z4-repeat array contraction to a size of 1-10 units (normal range 10-100 units). The less common form, FSHD2, is characterized by D4Z4 CpG hypomethylation and is most often caused by loss-of-function mutations in the structural maintenance of chromosomes hinge domain 1 (SMCHD1) gene on chromosome 18p. The chromatin modifier SMCHD1 is necessary to maintain a repressed D4Z4 chromatin state. Here, we describe two FSHD2 families with a 1.2-Mb deletion encompassing the SMCHD1 gene. Numerical aberrations of chromosome 18 are relatively common and the majority of 18p deleti...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25820463/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475473/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">The chromosomal protein SMCHD1 regulates DNA methylation and the 2c-like state of embryonic stem cells by antagonizing TET proteins.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Science advances | 
                    2021 | 
                    PMID: 33523915
                </div>
                <div class="pub-abstract">5-Methylcytosine (5mC) oxidases, the ten-eleven translocation (TET) proteins, initiate DNA demethylation, but it is unclear how 5mC oxidation is regulated. We show that the protein SMCHD1 (structural maintenance of chromosomes flexible hinge domain containing 1) is found in complexes with TET proteins and negatively regulates TET activities. Removal of SMCHD1 from mouse embryonic stem (ES) cells induces DNA hypomethylation, preferentially at SMCHD1 target sites and accumulation of 5-hydroxymethylcytosine (5hmC), along with promoter demethylation and activation of the </div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/33523915/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817097/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Inherited deletion of 9p22.3-p24.3 and duplication of 18p11.31-p11.32 associated with neurodevelopmental delay: Phenotypic matching of involved genes.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Journal of cellular and molecular medicine | 
                    2023 | 
                    PMID: 36691971
                </div>
                <div class="pub-abstract">We describe a 3.5-year-old Iranian female child and her affected 10-month-old brother with a maternally inherited derivative chromosome 9 [der(9)]. The postnatally detected rearrangement was finely characterized by aCGH analysis, which revealed a 15.056â€‰Mb deletion of 9p22.3-p24.3p22.3 encompassing 14 OMIM morbid genes such as DOCK8, KANK1, DMRT1 and SMARCA2, and a gain of 3.309â€‰Mb on 18p11.31-p11.32 encompassing USP14, THOC1, COLEC12, SMCHD1 and LPIN2. We aligned the genes affected by detected CNVs to clinical and functional phenotypic features using PhenogramViz. In this regard, the patient&#x27;s phenotype and CNVs data were entered into PhenogramViz. For the 9p deletion CNV, 53 affected genes were identified and 17 of them were matched to 24 HPO terms describing the patient&#x27;s phenotypes. Al...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36691971/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930415/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Transcriptional profiling of the epigenetic regulator Smchd1.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Genomics data | 
                    2016 | 
                    PMID: 26981392
                </div>
                <div class="pub-abstract">Smchd1 is an epigenetic repressor with important functions in healthy cellular processes and disease. To elucidate its role in transcriptional regulation, we performed two independent genome-wide RNA-sequencing studies comparing wild-type and Smchd1 null samples in neural stem cells and lymphoma cell lines. Using an R-based analysis pipeline that accommodates observational and sample-specific weights in the linear modeling, we identify key genes dysregulated by Smchd1 deletion such as clustered protocadherins in the neural stem cells and imprinted genes in both experiments. Here we provide a detailed description of this analysis, from quality control to read mapping and differential expression analysis. These data sets are publicly available from the Gene Expression Omnibus database (acces...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/26981392/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778621/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Neuromuscular disorders : NMD | 
                    2016 | 
                    PMID: 27061275
                </div>
                <div class="pub-abstract">Facioscapulohumeral muscular dystrophy 2 (FSHD2) is a genetic muscular disorder characterized by DNA hypomethylation on the 4q-subtelomeric macrosatellite repeat array, D4Z4. FSHD2 is caused by heterozygous mutations in the gene encoding structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1). Because there has been no study on FSHD2 in Asian populations, it is not known whether this disease mechanism is widely seen. To identify FSHD2 patients with SMCHD1 mutations in the Japanese population, bisulfite pyrosequencing was used to measure DNA methylation on the D4Z4 repeat array, and in patients with DNA hypomethylation, the SMCHD1 gene was sequenced by the Sanger method. Twenty patients with D4Z4 hypomethylation were identified. Of these, 13 patients from 11 unrela...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/27061275/" target="_blank">View on PubMed</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Whole Genome Linkage and Association Analyses Identify DLG Associated Protein-1 as a Novel Positional and Biological Candidate Gene for Muscle Strength: The Long Life Family Study.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    The journals of gerontology. Series A, Biological sciences and medical sciences | 
                    2024 | 
                    PMID: 38808484
                </div>
                <div class="pub-abstract">Grip strength is a robust indicator of overall health, is moderately heritable, and predicts longevity in older adults. Using genome-wide linkage analysis, we identified a novel locus on chromosome 18p (mega-basepair region: 3.4-4.0) linked to grip strength in 3Â 755 individuals from 582 families aged 64â€…Â±â€…12 years (range 30-110 years; 55% women). There were 26 families that contributed to the linkage peak (cumulative logarithm of the odds [LOD] scoreâ€…=â€…10.94), with 6 families (119 individuals) accounting for most of the linkage signal (LODâ€…=â€…6.4). In these 6 families, using whole genome sequencing data, we performed association analyses between the 7Â 312 single nucleotide (SNVs) and insertion deletion (INDELs) variants in the linkage region and grip strength. Models were adjusted for age, ...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/38808484/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226997/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">A Pediatric Review of Facioscapulohumeral Muscular Dystrophy.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Journal of pediatric neurology : JPN | 
                    2018 | 
                    PMID: 30923442
                </div>
                <div class="pub-abstract">Facioscapulohumeral dystrophy is one of the most common forms of muscular dystrophies worldwide. It is a complex and heterogeneous disease secondary to insufficient epigenetic repression of D4Z4 repeats and aberrant expression of </div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30923442/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435288/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <p style="text-align: center; color: #666; margin-top: 20px;">
                ... and 33 more publications
            </p>

        </div>
        
        <footer style="text-align: center; margin-top: 40px; padding-top: 20px; border-top: 1px solid #ddd; color: #666;">
            <p>Generated by K-Sites RAG System | Literature Mining with Semantic Analysis</p>
            <p>Using PubMed, PMC Open Access, and SentenceTransformer Embeddings</p>
        </footer>
    </div>
</body>
</html>
